These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1196 related articles for article (PubMed ID: 24727334)

  • 1. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
    Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience.
    Vogl UM; Nagayama K; Bojic M; Hoda MA; Klepetko W; Jaksch P; Dekan S; Siersch V; Mitterbauer M; Schellongowski P; Greinix HT; Petkov V; Schulenburg A; Kalhs P; Rabitsch W
    Transplantation; 2013 Feb; 95(4):623-8. PubMed ID: 23274967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of risk factors for bronchiolitis obliterans syndrome after reduced toxicity conditioning before hematopoietic cell transplantation.
    Duque-Afonso J; Ihorst G; Wäsch R; Bertz H; Müller-Quernheim J; Finke J; Prasse A; Marks R
    Bone Marrow Transplant; 2013 Aug; 48(8):1098-103. PubMed ID: 23376822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early outcomes of lung transplantation for bronchiolitis obliterans syndrome after allogeneic haematopoietic stem cell transplantation: a single-centre experience.
    Jung HS; Lee JG; Yu WS; Lee CY; Haam SJ; Paik HC
    Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):914-918. PubMed ID: 27481680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung transplantation following hematopoietic stem cell transplantation: report of two cases and systematic review of literature.
    Soubani AO; Kingah P; Alshabani K; Muma G; Haq A
    Clin Transplant; 2014 Jul; 28(7):776-82. PubMed ID: 24754643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity Conditioning.
    Duque-Afonso J; Ihorst G; Waterhouse M; Zeiser R; Wäsch R; Bertz H; Müller-Quernheim J; Finke J; Marks R; Prasse A
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2277-2284. PubMed ID: 29964193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies.
    Naik S; Martinez C; Leung K; Sasa G; Nguyen NY; Wu MF; Gottschalk S; Brenner M; Heslop H; Krance R
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1266-72. PubMed ID: 25765555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch.
    Slack JL; Dueck AC; Fauble VD; Sproat LO; Reeder CB; Noel P; Khera N; Betcher JA; Klein JL; Leis JF; Adams RH
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1167-74. PubMed ID: 23664940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma.
    Law LY; Horning SJ; Wong RM; Johnston LJ; Laport GG; Lowsky R; Shizuru JA; Blume KG; Negrin RS; Stockerl-Goldstein KE
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):703-11. PubMed ID: 16785059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pulmonary complications after nonmyeloablative and conventional allogeneic hematopoietic cell transplant.
    Diab KJ; Yu Z; Wood KL; Shmalo JA; Sheski FD; Farber MO; Wilkes DS; Nelson RP
    Biol Blood Marrow Transplant; 2012 Dec; 18(12):1827-34. PubMed ID: 22766224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.
    Dey BR; McAfee S; Sackstein R; Colby C; Saidman S; Weymouth D; Poliquin C; Vanderklish J; Sachs DH; Sykes M; Spitzer TR
    Biol Blood Marrow Transplant; 2001; 7(11):604-12. PubMed ID: 11760148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Krebs Von Den Lungen-6 as a Biomarker for Early Detection of Bronchiolitis Obliterans Syndrome in Children Undergoing Allogeneic Stem Cell Transplantation.
    Gassas A; Schechter T; Krueger J; Craig-Barnes H; Sung L; Ali M; Dell S; Egeler RM; Zaidman I; Palaniyar N
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1524-8. PubMed ID: 25963919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT.
    Holm AM; Riise GC; Hansson L; Brinch L; Bjørtuft O; Iversen M; Simonsen S; Fløisand Y
    Bone Marrow Transplant; 2013 May; 48(5):703-7. PubMed ID: 23064037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung transplantation for cystic fibrosis: 6-year follow-up.
    Quattrucci S; Rolla M; Cimino G; Bertasi S; Cingolani S; Scalercio F; Venuta F; Midulla F
    J Cyst Fibros; 2005 May; 4(2):107-14. PubMed ID: 15914093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation.
    Nakasone H; Kanda J; Yano S; Atsuta Y; Ago H; Fukuda T; Kakihana K; Adachi T; Yujiri T; Taniguchi S; Taguchi J; Morishima Y; Nagamura T; Sakamaki H; Mori T; Murata M;
    Transpl Int; 2013 Jun; 26(6):631-9. PubMed ID: 23551210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-lung transplantation: does side matter?
    Tsagkaropoulos S; Belmans A; Verleden GM; Coosemans W; Decaluwe H; De Leyn P; Nafteux P; Van Raemdonck D
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):e83-92. PubMed ID: 21497108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplantation.
    Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Liu KY; Huang XJ
    Chin Med J (Engl); 2013 Jul; 126(13):2489-94. PubMed ID: 23823823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of allogeneic haemopoietic stem cell transplants at a small New Zealand centre: does size matter?
    Ganly P; Cole S; Trengrove A; Butler A
    Intern Med J; 2014 Jul; 44(7):683-9. PubMed ID: 24750295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions.
    Hefazi M; Langer KJ; Khera N; Adamski J; Roy V; Winters JL; Gastineau DA; Jacob EK; Kreuter JD; Gandhi MJ; Hogan WJ; Litzow MR; Hashmi SK; Yadav H; Iyer VN; Scott JP; Wylam ME; Cartin-Ceba R; Patnaik MM
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1906-1913. PubMed ID: 29679771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.